Villalas, Diosdado C.

HRN: 22-45-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/07/2023
01/14/2023
IV
600mg
Q6
DM FOOT
Waiting Final Action 
01/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2023
01/21/2023
IV
4.5g
Q6
DM FOOT
Waiting Final Action 
01/10/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/10/2023
01/12/2023
PO
500mg
OD
Pneumonia
Waiting Final Action 
01/14/2023
AZITHROMYCIN 500MG TABLET (TAB)
01/14/2023
01/17/2023
PO
500mg
OD
Pneumonia
Waiting Final Action 
01/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/15/2023
01/22/2023
IV
4.5g
Q6h
Dm Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: